IL18 and diabetic kidney disease: In several inflammatory contexts, including diabetic nephropathy, miR-146a displayed an anti-inflammatory effect, since miR-146a deficiency during diabetes led to increased expression of M1 activation markers and proinflammatory cytokines (IL1β, IL18) and suppression of M2 markers in macrophages [41].